Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | ATM |
Variant | D1682H |
Impact List | missense |
Protein Effect | loss of function - predicted |
Gene Variant Descriptions | ATM D1682H does not lie within any known functional domains of the Atm protein (UniProt.org). D1682H results in failure to induce expression of TP53 target genes upon DNA damage in patient-derived cells in culture (PMID: 23585524), and therefore, is predicted to lead to a loss of Atm protein function. |
Associated Drug Resistance | |
Category Variants Paths |
ATM mutant ATM inact mut ATM D1682H |
Transcript | NM_000051.4 |
gDNA | chr11:g.108299752G>C |
cDNA | c.5044G>C |
Protein | p.D1682H |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_000051 | chr11:g.108299752G>C | c.5044G>C | p.D1682H | RefSeq | GRCh38/hg38 |
XM_017017792.2 | chr11:g.108299752G>C | c.5044G>C | p.D1682H | RefSeq | GRCh38/hg38 |
XM_011542840.4 | chr11:g.108299752G>C | c.5044G>C | p.D1682H | RefSeq | GRCh38/hg38 |
XM_047426976.1 | chr11:g.108299752G>C | c.5044G>C | p.D1682H | RefSeq | GRCh38/hg38 |
XM_017017790.3 | chr11:g.108299752G>C | c.5044G>C | p.D1682H | RefSeq | GRCh38/hg38 |
XM_011542843.3 | chr11:g.108299752G>C | c.5044G>C | p.D1682H | RefSeq | GRCh38/hg38 |
XM_017017791.1 | chr11:g.108299752G>C | c.5044G>C | p.D1682H | RefSeq | GRCh38/hg38 |
XM_011542840 | chr11:g.108299752G>C | c.5044G>C | p.D1682H | RefSeq | GRCh38/hg38 |
XM_006718843.4 | chr11:g.108299752G>C | c.5044G>C | p.D1682H | RefSeq | GRCh38/hg38 |
XM_006718843.5 | chr11:g.108299752G>C | c.5044G>C | p.D1682H | RefSeq | GRCh38/hg38 |
XM_017017789.2 | chr11:g.108299752G>C | c.5044G>C | p.D1682H | RefSeq | GRCh38/hg38 |
XM_011542843 | chr11:g.108299752G>C | c.5044G>C | p.D1682H | RefSeq | GRCh38/hg38 |
XM_017017789 | chr11:g.108299752G>C | c.5044G>C | p.D1682H | RefSeq | GRCh38/hg38 |
XM_005271562.5 | chr11:g.108299752G>C | c.5044G>C | p.D1682H | RefSeq | GRCh38/hg38 |
XM_011542840.3 | chr11:g.108299752G>C | c.5044G>C | p.D1682H | RefSeq | GRCh38/hg38 |
NM_001351834.2 | chr11:g.108299752G>C | c.5044G>C | p.D1682H | RefSeq | GRCh38/hg38 |
NM_001351834.1 | chr11:g.108299752G>C | c.5044G>C | p.D1682H | RefSeq | GRCh38/hg38 |
XM_005271562.6 | chr11:g.108299752G>C | c.5044G>C | p.D1682H | RefSeq | GRCh38/hg38 |
XM_006718843 | chr11:g.108299752G>C | c.5044G>C | p.D1682H | RefSeq | GRCh38/hg38 |
NM_000051.4 | chr11:g.108299752G>C | c.5044G>C | p.D1682H | RefSeq | GRCh38/hg38 |
XM_017017792 | chr11:g.108299752G>C | c.5044G>C | p.D1682H | RefSeq | GRCh38/hg38 |
XM_047426975.1 | chr11:g.108299752G>C | c.5044G>C | p.D1682H | RefSeq | GRCh38/hg38 |
XM_017017790 | chr11:g.108299752G>C | c.5044G>C | p.D1682H | RefSeq | GRCh38/hg38 |
XM_011542843.2 | chr11:g.108299752G>C | c.5044G>C | p.D1682H | RefSeq | GRCh38/hg38 |
NM_000051.3 | chr11:g.108299752G>C | c.5044G>C | p.D1682H | RefSeq | GRCh38/hg38 |
XM_017017791 | chr11:g.108299752G>C | c.5044G>C | p.D1682H | RefSeq | GRCh38/hg38 |
XM_005271561 | chr11:g.108299752G>C | c.5044G>C | p.D1682H | RefSeq | GRCh38/hg38 |
XM_005271562 | chr11:g.108299752G>C | c.5044G>C | p.D1682H | RefSeq | GRCh38/hg38 |
XM_017017790.2 | chr11:g.108299752G>C | c.5044G>C | p.D1682H | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|